Ingro Finanz AG is an investment holding company specialized in late stage venture investments.
Ingro Finance AG is a privately held Swiss company focusing on the purchase,administration and divestment of all types of participations. The investment portfolio of thecompany comprises amongst others participations in various life science companies.
Date
Company Name
|
Round | Money Raised | Industry | Lead Investor |
---|---|---|---|---|
May 12, 2009
NovImmune
|
Series Unknown | $54.80M | Biotechnology | — |
Sep 24, 2007
Ganymed Pharmaceuticals
|
Series C | €33.70M | Biopharma | — |
Ingro Finanz AG has had 1 exits. Ingro Finanz AG most notable exits include Ganymed Pharmaceuticals
Date | Company Name | Exit Type | Industry | |
---|---|---|---|---|
Oct 28, 2016 | Ganymed Pharmaceuticals | M&A | Biopharma | Detail |